Vultaggio Vincent bought ZNTL
February 3, 2025 · Form 4 insider transaction
Vultaggio Vincent bought 158,586 shares of Zentalis Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
158,586
Price
$0.00
Total value
N/A
InsiderVultaggio Vincent
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 3, 2025
Filing dateFebruary 5, 2025
Shares owned after192,441
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a two year period following the grant date, subject to the Reporting Person's continued service with the Issuer.